Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Quadracel |
| Active Ingredients: | Diphtheria toxoid, adsorbed 15Lf U Pertactin 3mcg Pertussis filamentous haemagglutinin 20mcg Pertussis fimbriae 2+3 5mcg Pertussis toxoid, adsorbed 20mcg Polio virus type 1 40DAgU Polio virus type 2 8DAgU Polio virus type 3 32DAgU Tetanus toxoid, adsorbed 5Lf U |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturers: | Sanofi Pasteur Inc, Pennsylvania, United States of America Sanofi Pasteur Limited, Ontario, Canada |
Dated this 25th day of November 2022.
MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).